Item 8.01. Other Events.

On May 13, 2009, POZEN Inc., a Delaware corporation ("POZEN"), issued a press release announcing that AstraZeneca has made the decision to have POZEN file the New Drug Application for PN400 with the United States Food and Drug Administration. A copy of POZEN's press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description

99.1 Press Release of POZEN Inc. dated May 13, 2009.

- 2 -

---